A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : TACE

Search Conditions:
Search Keyword : TACE
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: TACE
Appearance Frequency: 3880 time(s)
Long forms: 46

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
transarterial chemoembolization
(3241 times)
Neoplasms
(912 times)
HCC (2134 times)
OS (363 times)
RFA (305 times)
1985 [A newly devised chemo-embolic agent, G. T. XIII-ADM].
TNF-alpha converting enzyme
(300 times)
Biochemistry
(46 times)
TNF-alpha (61 times)
TNF (50 times)
EGFR (18 times)
1997 Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha.
tumor necrosis factor-alpha converting enzyme
(242 times)
Biochemistry
(76 times)
PMA (29 times)
EGFR (20 times)
ERK (19 times)
1997 2 angstrom X-ray structure of adamalysin II complexed with a peptide phosphonate inhibitor adopting a retro-binding mode.
TACE group
(16 times)
Neoplasms
(4 times)
HCC (14 times)
RFA (7 times)
OS (4 times)
2002 Influence of preoperative transcatheter arterial chemoembolization on liver resection in patients with resectable hepatocellular carcinoma.
TNF-alpha convertase
(14 times)
Neurology
(3 times)
TNF-alpha (9 times)
iNOS (3 times)
ADAM (2 times)
1999 Evidence for a role of a tumor necrosis factor-alpha (TNF-alpha)-converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival.
tumour necrosis factor alpha convertase
(11 times)
Biochemistry
(5 times)
autoAbs (1 time)
DRM (1 time)
EGFR (1 time)
1999 Evidence for an interaction of the metalloprotease-disintegrin tumour necrosis factor alpha convertase (TACE) with mitotic arrest deficient 2 (MAD2), and of the metalloprotease-disintegrin MDC9 with a novel MAD2-related protein, MAD2beta.
Tolerance, Annoyed, Cut down, Eye-opener
(6 times)
Obstetrics
(2 times)
AUDIT (3 times)
AUDIT-C (1 time)
AUROC (1 time)
2007 Estimates of prenatal abstinence from alcohol: a matter of perspective.
TNFalpha cleaving enzyme
(4 times)
Endocrinology
(1 time)
TNF-alpha (2 times)
GHR (1 time)
JAK2 (1 time)
2002 Application of peptides containing the cleavage sequence of pro-TNFalpha in assessing TACE activity of whole cells.
trip-anisyl chloroethylene
(4 times)
Gynecology
(2 times)
--- 1952 Estrogenic effect of tri-p-anisylchloroethylene (TACE) in the human postmenopausal female.
10  transhepatic arterial chemotherapy and embolization
(3 times)
Neoplasms
(2 times)
HCC (2 times)
AFP (1 time)
CT (1 time)
2016 Effect of adjuvant interferon therapy on hepatitis B virus-related hepatocellular carcinoma: a systematic review.
11  TNF cleavage enzyme
(2 times)
Genetics, Medical
(1 time)
SNPs (1 time)
2010 Polymorphisms spanning the TNFR2 and TACE genes do not contribute towards variable anti-TNF treatment response.
12  transcatheter arterial chemoembolization using Lipiodol
(2 times)
Gastroenterology
(2 times)
HCC (1 time)
RHCC (1 time)
1993 Chemoembolotherapy for recurrent hepatocellular carcinoma in the residual liver after hepatectomy.
13  tumor necrosis factor alpha converting enzyme activation
(2 times)
Hematology
(1 time)
CLL (1 time)
M-CSF (1 time)
NF-kappaB (1 time)
2014 Breast tumor cell TACE-shed MCSF promotes pro-angiogenic macrophages through NF-kappaB signaling.
14  activity to alpha-secretase
(1 time)
Biology
(1 time)
--- 2013 beta-Secretase (BACE1) inhibitory property of loganin isolated from Corni fructus.
15  either a chemotherapy
(1 time)
Neoplasms
(1 time)
MWA (1 time)
PEI (1 time)
PVE (1 time)
2017 Other non-surgical treatments for liver cancer.
16  Furin-TNF-alpha-converting enzyme
(1 time)
Clinical Laboratory Techniques
(1 time)
Abs (1 time)
SGECs (1 time)
2010 RETRACTED: Blockade of TNF-alpha signaling suppresses the AREG-mediated IL-6 and IL-8 cytokines secretion induced by anti-Ro/SSA autoantibodies.
17  TACE without endostatin
(1 time)
Gastroenterology
(1 time)
HCC (1 time)
MVD (1 time)
TACE-V (1 time)
2012 Endostatin inhibits angiogenesis in hepatocellular carcinoma after transarterial chemoembolization.
18  TACE-BEV arm
(1 time)
Neoplasms
(1 time)
HCC (1 time)
OS (1 time)
PFS (1 time)
2012 Transarterial chemoembolization plus or minus intravenous bevacizumab in the treatment of hepatocellular cancer: a pilot study.
19  TACE-DEB is described
(1 time)
Radiology
(1 time)
--- 2014 Medico-economic study of the management of hepatocellular carcinoma by chemo-embolization.
20  TAPI-1, an inhibitor of another enzyme required for notch activity
(1 time)
Neurology
(1 time)
--- 2011 Inhibition of Notch activity promotes nonmitotic regeneration of hair cells in the adult mouse utricles.
21  Targeted Analysis of Chromatin Events
(1 time)
Molecular Biology
(1 time)
--- 2020 Targeted Analysis of Chromatin Events (TACE).
22  targeting of cell surface metalloprotease
(1 time)
Biological Phenomena
(1 time)
IBD (1 time)
2017 Increased Potency of a Bi-specific TL1A-ADAM17 (TACE) Inhibitor by Cell Surface Targeting.
23  Technology-assisted continuing education
(1 time)
Education, Nursing
(1 time)
--- 2019 Improving End-of-Life Communications Using Technology-Assisted Continuing Education With Interprofessional Teams.
24  TNF-alpha ADAM metalloprotease converting enzyme
(1 time)
Cell Biology
(1 time)
AhR (1 time)
BSG (1 time)
IL-22 (1 time)
2017 Gene expression profiling of the Notch-AhR-IL22 axis at homeostasis and in response to tissue injury.
25  TNF-cleaving enzyme
(1 time)
Neurology
(1 time)
mTNFalpha (1 time)
SP (1 time)
sTNFalpha (1 time)
2010 A novel cell-cell signaling by microglial transmembrane TNFalpha with implications for neuropathic pain.
26  transarterial chemoembolization chemoembolization
(1 time)
Radiology
(1 time)
CT (1 time)
HCC (1 time)
OS (1 time)
2012 CT-guided radiofrequency ablation after with transarterial chemoembolization in treating unresectable hepatocellular carcinoma with long overall survival improvement.
27  transarterial chemoembolization using lipiodol +/- gelatin sponge particles
(1 time)
Neoplasms
(1 time)
HCC (1 time)
PVTT (1 time)
2017 The degree of hepatic arterial blood supply of portal vein tumor thrombus in patients with hepatocellular carcinoma and its impact on overall survival after transarterial chemoembolization.
28  transarterial chemoembolization with CPT-11 charged microbeads
(1 time)
Neoplasms
(1 time)
--- 2015 A retrospective analysis of 141 patients with liver metastases from uveal melanoma: a two-cohort study comparing transarterial chemoembolization with CPT-11 charged microbeads and historical treatments.
29  transarterial chemotherapy
(1 time)
Medicine
(1 time)
SIRT (1 time)
2018 [Hepatocellular Carcinoma: New multimodal therapy concepts].
30  transarterial platinum coil embolization
(1 time)
Brain
(1 time)
CCF (1 time)
TABE (1 time)
1997 [Transarterial platinum coil embolization for direct carotid-cavernous fistula].
31  transcatheter
(1 time)
Pharmacology
(1 time)
HCC (1 time)
MVD (1 time)
PI3K (1 time)
2015 Inhibition of human hepatocellular carcinoma tumor angiogenesis by siRNA silencing of VEGF via hepatic artery perfusion.
32  transcatheter arterial chemoembolization using iodized oil mixed with anticancer drugs
(1 time)
Radiology
(1 time)
HCC (1 time)
RFA (1 time)
2005 [Low-output radiofrequency ablation combined with transcatheter arterial oily-chemoembolization for hepatocellular carcinoma].
33  transcatheter arterial chemoembolization/transarterial chemoembolization
(1 time)
Drug Therapy
(1 time)
HCC (1 time)
mAbs (1 time)
2017 Recent advances in hepatocellular carcinoma therapy.
34  transcatheter arterial infusion chemotherapy
(1 time)
Radiology
(1 time)
ASC (1 time)
DSM (1 time)
2004 Case report: adenosquamous carcinoma of the liver successfully treated with repeated transcatheter arterial infusion chemotherapy (TACE) with degradable starch microspheres.
35  transhepatic arterial chemotherapeutic embolism
(1 time)
Neoplasms
(1 time)
HGF (1 time)
PLC (1 time)
2017 Effects of HGF gene polymorphisms and protein expression on transhepatic arterial chemotherapeutic embolism efficacy and prognosis in patients with primary liver cancer.
36  treated with chemoembolization
(1 time)
Gastroenterology
(1 time)
PVT (1 time)
2010 Chemoembolization for unresectable hepatocellular carcinoma in patients with or without portal vein thrombosis.
37  treatment for recurrence
(1 time)
General Surgery
(1 time)
HCC (1 time)
OS (1 time)
RTDS (1 time)
2015 Early intrahepatic recurrence of hepatocellular carcinoma after hepatectomy treated with re-hepatectomy, ablation or chemoembolization: a prospective cohort study.
38  Treatment of cancer of prostate & its metastases by chlorotrianisene
(1 time)
Urology
(1 time)
--- 1957 [Treatment of cancer of prostate & its metastases by chlorotrianisene (TACE)].
39  treatment of intermediate-stage HCC, i.e. BCLC's stage B, is chemoembolization
(1 time)
Neoplasms
(1 time)
BCLC (1 time)
HCC (1 time)
HIF-1 (1 time)
2012 Effective therapeutic management of hepatocellular carcinoma - on the basis of a clinical case.
40  treatment response after chemoembolisation
(1 time)
Hematology
(1 time)
CEUS (1 time)
CT (1 time)
HCC (1 time)
2014 Evaluation of treatment response after chemoembolisation (TACE) in hepatocellular carcinoma using real time image fusion of contrast-enhanced ultrasound (CEUS) and computed tomography (CT)--preliminary results.
41  treatment with chlorotrianisene
(1 time)
Urology
(1 time)
--- 1983 New approach in the treatment of prostate cancer: complete instead of partial withdrawal of androgens.
42  trial of intraarterial hepatic chemoembolization
(1 time)
Neoplasms
(1 time)
--- 2007 Intraarterial hepatic chemoembolization of liver metastases from colorectal cancer adopting irinotecan-eluting beads: results of a phase II clinical study.
43  tumor model of hepatic arterial chemoembolization
(1 time)
Neoplasms
(1 time)
AUC (1 time)
GSMs (1 time)
2014 Pharmacokinetics of gelatin sponge microparticles in a rabbit VX2 liver tumor model of hepatic arterial chemoembolization.
44  tumor necrosis factor-alpha
(1 time)
Chemistry
(1 time)
MMP (1 time)
2004 Synthesis and structure-activity relationships of 4-alkynyloxy phenyl sulfanyl, sulfinyl, and sulfonyl alkyl hydroxamates as tumor necrosis factor-alpha converting enzyme and matrix metalloproteinase inhibitors.
45  tumors, chemoembolization
(1 time)
TAE (1 time)
TARE (1 time)
2015 Arterial Therapies of Non-Colorectal Liver Metastases.
46  Tumour Necrosis Factor-alpha Cleaving Enzyme
(1 time)
Pathology
(1 time)
MMP (1 time)
2000 Treatment with BB-94, a broad spectrum inhibitor of zinc-dependent metalloproteinases, causes deviation of the cytokine profile towards type-2 in experimental pulmonary tuberculosis in Balb/c mice.